Abstract:Background: Hedgehog (Hh) signaling pathway, which is essential for cell proliferation and differentiation, is noted to be aberrantly activated in tumor from increasing studies in recent years. MicroRNAs (miRNAs) as an important non-coding RNA in cells have been proven to possess a regulatory role specific to the Hh signaling pathway. Here, in vitro and in vivo cellular/molecular experiments were adopted to clarify the regulatory mechanism linking miR-636 to the Hh signaling pathway in ovarian cancer (OVC). Methods: Protein-protein interaction analysis was performed to identify the hub gene in the Hh pathway. TargetScan database was used to predict the potential upstream regulators for Gli2. qRT-PCR was performed to test the expression of miR-636, while Western blot was conducted to detect the expression of proteins related to the Hh pathway and epithelial-mesenchymal transition (EMT). For cell functional experiments, HO-8910PM OVC cell line was used. MTT assay and wound healing assay were used to measure the effect of miR-636 on cell proliferation and migration. Flow cytometry was carried out to examine the effect of miR-636 on cell cycle, and Western blot was used to identify the change in expression of Hh and EMT-related proteins. Dual-luciferase reporter gene assay was implemented to detect the targeting relationship between miR-636 and Gli2. Xenotransplantation models were established for in vivo examination. Results: Gli2 was identified as the hub gene of the Hh pathway and it was validated to be regulated by miR-636 based on the data from TargetScan and GEO databases. In vitro experiments discovered that miR-636 was significantly lowly expressed in OVC cell lines, and overexpressing miR-636 significantly inhibited HO-8910PM cell proliferation, migration and induced cell cycle arrest in G0/G1 phase, while the inhibition of miR-636 caused opposite results. Dual-luciferase reporter gene assay revealed that Gli2 was the target gene of miR-636 in OVC. Besides, overexpressed miR-636 decreased protein expression of Gli2, and affected the expression of proteins related to the Hh signaling pathway and EMT. Rescue experiments verified that overexpression of Gli2 reversed the inhibitory effect of miR-636 on HO-8910PM cell proliferation and migration, and attenuated the blocking effect of miR-636 on cell cycle. The xenotransplantation experiment suggested that miR-636 inhibited cell growth of OVC by decreasing Gli2 expression. Besides, overexpressing Gli2 potentiated the EMT process of OVC cells via decreasing E-cadherin protein expression and increasing Vimentin protein expression, and it reversed the inhibitory effect of miR-636 on OVC cell proliferation in vivo . Conclusion: miR-636 mediates the activation of the Hh pathway via binding to Gli2, thus inhibiting EMT, suppressing cell proliferation and migration of OVC. Trial registration: The experimental protocol was established, according to the ethical guidelines of the Helsinki Declaration and was approved by the Human Ethics Committee of The Second Affiliated hospital of Zhejiang University School of Medicine (IR2019001235). Written informed consent was obtained from individual or guardian participants.

& It;Ovostatin & It; 2 Knockdown Significantly Inhibits The Growth, Migration, And Tumorigenicity Of Cutaneous Malignant Melanoma Cells

MCAM is Associated with Metastasis and Poor Prognosis in Osteosarcoma by Modulating Tumor Cell Migration

Expression Analysis of Ovostatin 2 Reveals Its Involvement in Proliferation, Invasion and Angiogenesis of Cutaneous Malignant Melanoma.

Downregulation of Hsa_circ_0026123 Suppresses Ovarian Cancer Cell Metastasis and Proliferation Through the Mir‑124‑3p/ezh2 Signaling Pathway.

Orosomucoid 2 Inhibits Tumor Metastasis and is Upregulated by CCAAT/enhancer Binding Protein Β in Hepatocellular Carcinomas

OVOL2 Attenuates the Expression of MAP3K8 to Suppress Epithelial Mesenchymal Transition in Colorectal Cancer.

OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and is Down-regulated in Human Colorectal Tumors.

miR-636 Inhibits EMT, Cell Proliferation and Cell Cycle of Ovarian Cancer by Directly Targeting the Transcription Factor Gli2 of Hedgehog Pathway

Ova66 Increases Cell Growth, Invasion and Survival Via Regulation of Igf-1r-Mapk Signaling in Human Cancer Cells

Long Non-Coding RNA SOX2OT Promotes Cell Proliferation and Motility in Human Ovarian Cancer

Oncostatin M Promotes Proliferation of Ovarian Cancer Cells Through Signal Transducer and Activator of Transcription 3

Mir-636 Inhibits EMT, Cell Proliferation and Cell Cycle of Ovarian Cancer by Directly Targeting Transcription Factor Gli2 Involved in Hedgehog Pathway

OVOL2 Antagonizes TGF-β Signaling to Regulate Epithelial to Mesenchymal Transition During Mammary Tumor Metastasis

OVOL2 inhibits macrophage M2 polarization by regulating IL-10 transcription, and thus inhibits the tumor metastasis by modulating the tumor microenvironment

Original Article: Increased expression of MAP2 inhibits melanoma cell proliferation, invasion and tumor growth in vitro and in vivo: MAP2 inhibits melanoma cell proliferation and invasion

Ectopic repression of receptor tyrosine kinase–like orphan receptor 2 inhibits malignant transformation of ovarian cancer cells by reversing epithelial–mesenchymal transition

OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma.

Downregulation of Microrna-586 Inhibits Proliferation, Invasion and Metastasis and Promotes Apoptosis in Human Osteosarcoma U2-OS Cell Line

MAD2L2, a key regulator in ovarian cancer and promoting tumor progression

MicroRNA-192 Inhibits the Proliferation, Migration and Invasion of Osteosarcoma Cells and Promotes Apoptosis by Targeting Matrix Metalloproteinase-11.

Upregulation of miR-874-3p and miR-874-5p inhibits epithelial ovarian cancer malignancy via SIK2.